Commentary
Oral analgesic formulations containing paracetamol in combination with a centrally acting opioid analgesic such as codeine are commonly prescribed for the management of post-operative pain. This paper describes a systematic review of published randomized placebo-controlled clinical trials that evaluated either paracetamol alone or paracetamol plus codeine. Individual studies of paracetamol or codeine, when administered at therapeutic doses, generally confirm that (1) both agents are more effective than placebo and (2) paracetamol is a more effective analgesic than codeine. Individual studies of combination formulations, however, do not consistently demonstrate a statistically significant additive analgesic response. This quantitative systematic review confirms the analgesic efficacy of combined paracetamol plus codeine formulations.
Meta-analyses of analgesic drug efficacy studies require a common outcome measure for measuring pain relief. The outcome measures most frequently used in the third molar extraction model were established by Cooper and Beaver almost 25 years ago 1 . These include pain intensity difference (PID) from baseline at a given time, the summation of pain intensity differences for the duration of the study (SPIDs), pain relief from baseline at a given time (PARs) and the summation of pain relief for the duration of the study (TOTPARs). Other subjective pain measures are based on changes in pain experience quantified using visual analogue scales (VAS). Although these pain measures have been shown to be valid, they tend to have skewed distributions and overestimate efficacy if dropout rates are high.
The authors of this review derive a dichotomous measure called`numberneeded-to-treat' (NNT), which avoids comparing mean pain relief values. The NNT estimates the number of subjects who would have got at least 50% pain relief who would not have if they received an alternative agent or placebo. Although the definition of this measure is somewhat cumbersome, it provides a concise summary value with 95% confidence limits that has been used previously to estimate analgesic efficacy.
The authors have provided a rigorous review of the efficacy of this common analgesic drug combination that supports its use in acute dental post-operative pain management. However, one should appreciatethelimitationsoftheirfindings.The conclusion is dependent upon using the full therapeutic codeine dose of 60 mg; formulations using 15 or 30 mg of codeine may not provide significant improvement in analgesia. Additionally, the combination is likely to induce a higher incidence of nausea and vomiting, an adverse reaction that is likely following outpatient oral surgery. Neither of these clinically important issues has been addressed in this analysis. 
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